Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary ACTH Hypersecretion | 18 | 2024 | 176 | 3.650 |
Why?
|
Pituitary Neoplasms | 37 | 2024 | 1340 | 3.220 |
Why?
|
Acromegaly | 18 | 2022 | 347 | 1.790 |
Why?
|
Adenoma | 26 | 2022 | 2168 | 1.670 |
Why?
|
Cushing Syndrome | 8 | 2021 | 249 | 0.900 |
Why?
|
Petrosal Sinus Sampling | 3 | 2021 | 23 | 0.890 |
Why?
|
Central Nervous System Cysts | 2 | 2020 | 58 | 0.820 |
Why?
|
Adrenocorticotropic Hormone | 11 | 2022 | 648 | 0.770 |
Why?
|
Radiosurgery | 5 | 2020 | 1309 | 0.680 |
Why?
|
Pituitary Gland | 8 | 2021 | 665 | 0.680 |
Why?
|
Sella Turcica | 3 | 2010 | 119 | 0.570 |
Why?
|
Monitoring, Intraoperative | 2 | 2019 | 953 | 0.540 |
Why?
|
Pituitary Diseases | 3 | 2016 | 141 | 0.540 |
Why?
|
Neurosurgical Procedures | 5 | 2020 | 2002 | 0.520 |
Why?
|
Pituitary Apoplexy | 1 | 2014 | 30 | 0.490 |
Why?
|
Salvage Therapy | 1 | 2020 | 1269 | 0.470 |
Why?
|
Antidotes | 1 | 2014 | 138 | 0.460 |
Why?
|
Somatostatin | 7 | 2020 | 459 | 0.450 |
Why?
|
Prolactinoma | 6 | 2022 | 113 | 0.410 |
Why?
|
Blood Coagulation Factors | 1 | 2014 | 355 | 0.410 |
Why?
|
Hydrocortisone | 11 | 2024 | 1825 | 0.400 |
Why?
|
Sphenoid Bone | 3 | 2014 | 172 | 0.400 |
Why?
|
Human Growth Hormone | 7 | 2020 | 683 | 0.380 |
Why?
|
Hypopituitarism | 4 | 2023 | 254 | 0.350 |
Why?
|
Nose | 1 | 2012 | 509 | 0.320 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 854 | 0.320 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9185 | 0.290 |
Why?
|
Dopamine Agonists | 3 | 2020 | 355 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 15 | 2021 | 35342 | 0.280 |
Why?
|
Warfarin | 1 | 2014 | 1493 | 0.270 |
Why?
|
Insulin-Like Growth Factor I | 10 | 2020 | 2014 | 0.250 |
Why?
|
Receptors, Somatotropin | 3 | 2020 | 76 | 0.250 |
Why?
|
Adrenal Insufficiency | 3 | 2024 | 184 | 0.240 |
Why?
|
Hypophysectomy | 2 | 2021 | 113 | 0.240 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 4 | 2020 | 45 | 0.230 |
Why?
|
Corticotropin-Releasing Hormone | 3 | 2012 | 369 | 0.230 |
Why?
|
Hyperprolactinemia | 2 | 2022 | 129 | 0.220 |
Why?
|
Saliva | 2 | 2018 | 805 | 0.220 |
Why?
|
Brain Injuries | 1 | 2014 | 2024 | 0.210 |
Why?
|
Brain Neoplasms | 4 | 2020 | 8829 | 0.210 |
Why?
|
Receptors, Somatostatin | 2 | 2020 | 129 | 0.190 |
Why?
|
Retrospective Studies | 26 | 2024 | 77098 | 0.190 |
Why?
|
Body Composition | 5 | 2017 | 2400 | 0.190 |
Why?
|
Middle Aged | 52 | 2023 | 213127 | 0.180 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2020 | 46 | 0.180 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 603 | 0.170 |
Why?
|
Treatment Outcome | 14 | 2023 | 62966 | 0.170 |
Why?
|
Reoperation | 3 | 2022 | 4200 | 0.170 |
Why?
|
Frozen Sections | 1 | 2019 | 155 | 0.170 |
Why?
|
Adult | 54 | 2022 | 213712 | 0.170 |
Why?
|
Ependymoma | 3 | 2010 | 333 | 0.160 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 155 | 0.160 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 19 | 0.160 |
Why?
|
Humans | 79 | 2024 | 742088 | 0.150 |
Why?
|
Albuterol | 1 | 1998 | 208 | 0.150 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 401 | 0.150 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1255 | 0.150 |
Why?
|
Male | 53 | 2021 | 349538 | 0.140 |
Why?
|
Female | 58 | 2021 | 379592 | 0.140 |
Why?
|
Aged | 34 | 2020 | 162944 | 0.140 |
Why?
|
Intraoperative Period | 2 | 2019 | 520 | 0.140 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2016 | 238 | 0.130 |
Why?
|
Cytodiagnosis | 1 | 2019 | 435 | 0.130 |
Why?
|
Combined Modality Therapy | 6 | 2020 | 8621 | 0.130 |
Why?
|
Drainage | 1 | 2020 | 1140 | 0.130 |
Why?
|
Consensus | 2 | 2021 | 2935 | 0.120 |
Why?
|
Radiotherapy | 2 | 2020 | 1525 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 974 | 0.120 |
Why?
|
Karnofsky Performance Status | 1 | 2014 | 173 | 0.120 |
Why?
|
Craniotomy | 2 | 1996 | 729 | 0.120 |
Why?
|
Anti-Asthmatic Agents | 1 | 1998 | 533 | 0.120 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1999 | 740 | 0.110 |
Why?
|
Salivary Glands | 1 | 1995 | 228 | 0.110 |
Why?
|
Thyrotropin | 2 | 2014 | 850 | 0.110 |
Why?
|
Craniopharyngioma | 2 | 2010 | 281 | 0.110 |
Why?
|
Choristoma | 1 | 1995 | 213 | 0.110 |
Why?
|
Adolescent | 21 | 2021 | 85649 | 0.110 |
Why?
|
International Normalized Ratio | 1 | 2014 | 365 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1675 | 0.110 |
Why?
|
Growth Hormone | 6 | 2022 | 703 | 0.110 |
Why?
|
Hormone Replacement Therapy | 2 | 2010 | 744 | 0.110 |
Why?
|
Glasgow Coma Scale | 1 | 2014 | 570 | 0.110 |
Why?
|
Spinal Cord Neoplasms | 1 | 1995 | 281 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2130 | 0.100 |
Why?
|
Chordoma | 1 | 1995 | 359 | 0.100 |
Why?
|
Patient Care Team | 2 | 2020 | 2527 | 0.100 |
Why?
|
Cysts | 1 | 2016 | 676 | 0.100 |
Why?
|
Plasma | 1 | 2014 | 575 | 0.100 |
Why?
|
Aged, 80 and over | 12 | 2020 | 57683 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7276 | 0.090 |
Why?
|
Brain Stem | 2 | 1995 | 844 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2011 | 331 | 0.090 |
Why?
|
Spinal Diseases | 1 | 2014 | 538 | 0.090 |
Why?
|
Pituitary Gland, Posterior | 1 | 2008 | 43 | 0.080 |
Why?
|
Recurrence | 4 | 2015 | 8333 | 0.080 |
Why?
|
Adrenalectomy | 1 | 2011 | 342 | 0.080 |
Why?
|
Proteins | 3 | 2011 | 6096 | 0.080 |
Why?
|
Nelson Syndrome | 1 | 2007 | 20 | 0.080 |
Why?
|
DNA, Intergenic | 1 | 2008 | 107 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3471 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4553 | 0.080 |
Why?
|
Ki-67 Antigen | 2 | 2008 | 644 | 0.080 |
Why?
|
Gene Silencing | 2 | 2011 | 1538 | 0.080 |
Why?
|
Young Adult | 9 | 2020 | 56350 | 0.070 |
Why?
|
Inhibins | 2 | 2000 | 211 | 0.070 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1016 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2885 | 0.070 |
Why?
|
Microsurgery | 1 | 2012 | 796 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14720 | 0.070 |
Why?
|
Remission Induction | 3 | 2021 | 2384 | 0.070 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2006 | 62 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2012 | 1520 | 0.070 |
Why?
|
Morbidity | 2 | 2003 | 1767 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2017 | 3278 | 0.070 |
Why?
|
Tumor Burden | 2 | 2022 | 1905 | 0.060 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.060 |
Why?
|
Meningioma | 2 | 2010 | 1209 | 0.060 |
Why?
|
ROC Curve | 2 | 2020 | 3528 | 0.060 |
Why?
|
Quality of Life | 5 | 2023 | 12730 | 0.060 |
Why?
|
Child | 10 | 2014 | 77478 | 0.060 |
Why?
|
Growth Disorders | 1 | 2009 | 643 | 0.060 |
Why?
|
Dexamethasone | 2 | 2009 | 1949 | 0.060 |
Why?
|
Postoperative Complications | 7 | 2018 | 15244 | 0.060 |
Why?
|
Intracranial Aneurysm | 2 | 1996 | 1197 | 0.060 |
Why?
|
False Negative Reactions | 1 | 2004 | 587 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 13256 | 0.060 |
Why?
|
Octreotide | 2 | 2017 | 145 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2011 | 7873 | 0.050 |
Why?
|
Gene Expression | 3 | 2002 | 7790 | 0.050 |
Why?
|
Postoperative Period | 2 | 2020 | 1839 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3461 | 0.050 |
Why?
|
Prolactin | 2 | 2022 | 669 | 0.050 |
Why?
|
Endoscopy | 1 | 2012 | 1774 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2572 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 12958 | 0.050 |
Why?
|
Receptors, Growth Factor | 2 | 2000 | 334 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15056 | 0.050 |
Why?
|
Carotid Artery Diseases | 1 | 1987 | 882 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6534 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39004 | 0.040 |
Why?
|
Time | 1 | 2021 | 530 | 0.040 |
Why?
|
Asthma | 1 | 1998 | 5955 | 0.040 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1999 | 31 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 24913 | 0.040 |
Why?
|
Receptors, Neuropeptide | 1 | 1999 | 111 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5385 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 7716 | 0.040 |
Why?
|
Anticoagulants | 1 | 2014 | 4595 | 0.040 |
Why?
|
Hypothalamic Hormones | 1 | 1999 | 147 | 0.040 |
Why?
|
Matched-Pair Analysis | 1 | 1999 | 288 | 0.040 |
Why?
|
Postoperative Care | 1 | 2005 | 1484 | 0.040 |
Why?
|
Health Care Costs | 1 | 2012 | 3203 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2006 | 13029 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1271 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 12695 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 21719 | 0.040 |
Why?
|
Ergolines | 1 | 2017 | 60 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1999 | 314 | 0.040 |
Why?
|
Growth Substances | 1 | 2000 | 783 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2948 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 9941 | 0.040 |
Why?
|
Hospital Costs | 1 | 2003 | 980 | 0.040 |
Why?
|
Time Factors | 5 | 2020 | 40054 | 0.040 |
Why?
|
Lipodystrophy | 1 | 2017 | 147 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11363 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1526 | 0.030 |
Why?
|
Cranial Fossa, Posterior | 1 | 1996 | 139 | 0.030 |
Why?
|
Basilar Artery | 1 | 1996 | 200 | 0.030 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 138 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1996 | 192 | 0.030 |
Why?
|
Galactorrhea | 1 | 1995 | 24 | 0.030 |
Why?
|
Testosterone | 1 | 2006 | 2401 | 0.030 |
Why?
|
Circadian Rhythm | 2 | 2018 | 2623 | 0.030 |
Why?
|
Calcium-Binding Proteins | 2 | 2011 | 1081 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12344 | 0.030 |
Why?
|
Survival Rate | 2 | 1999 | 12773 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1150 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29010 | 0.030 |
Why?
|
DNA Methylation | 1 | 2008 | 4282 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 1998 | 1613 | 0.030 |
Why?
|
Neuropeptides | 1 | 1999 | 942 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13655 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 53187 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 711 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 545 | 0.030 |
Why?
|
Subcutaneous Fat | 1 | 2016 | 391 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1998 | 1118 | 0.030 |
Why?
|
Hospitals, General | 1 | 1997 | 749 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1567 | 0.030 |
Why?
|
Skull Base | 1 | 1996 | 299 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 965 | 0.030 |
Why?
|
Statistics as Topic | 1 | 1999 | 2372 | 0.030 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1991 | 98 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 1995 | 401 | 0.030 |
Why?
|
Skull Neoplasms | 1 | 1992 | 173 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1873 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2906 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 591 | 0.020 |
Why?
|
Cerebellum | 2 | 1996 | 1490 | 0.020 |
Why?
|
Rhinoplasty | 1 | 1995 | 226 | 0.020 |
Why?
|
Sacrococcygeal Region | 1 | 1991 | 52 | 0.020 |
Why?
|
Radiotherapy, Conformal | 1 | 2014 | 548 | 0.020 |
Why?
|
Endocrinology | 1 | 1997 | 443 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 1997 | 932 | 0.020 |
Why?
|
Gonadotropins | 1 | 1991 | 241 | 0.020 |
Why?
|
Blood Glucose | 2 | 2017 | 6249 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2006 | 10472 | 0.020 |
Why?
|
Spinal Nerves | 1 | 1990 | 86 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2186 | 0.020 |
Why?
|
Aftercare | 1 | 2016 | 860 | 0.020 |
Why?
|
Chondrosarcoma | 1 | 1992 | 309 | 0.020 |
Why?
|
Hospitals | 1 | 2003 | 3937 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2003 | 5310 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2006 | 12017 | 0.020 |
Why?
|
Neurosurgery | 1 | 1996 | 642 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1509 | 0.020 |
Why?
|
Sarcoma | 2 | 2008 | 1895 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 1990 | 161 | 0.020 |
Why?
|
Neurology | 1 | 1997 | 762 | 0.020 |
Why?
|
Trigeminal Nerve | 1 | 1990 | 249 | 0.020 |
Why?
|
Fathers | 1 | 2011 | 357 | 0.020 |
Why?
|
Disabled Persons | 1 | 1998 | 1209 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2009 | 13921 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19862 | 0.020 |
Why?
|
Encephalocele | 1 | 1989 | 135 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2006 | 6313 | 0.020 |
Why?
|
Intermediate Filaments | 1 | 2008 | 175 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2000 | 4751 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2014 | 2876 | 0.020 |
Why?
|
Bromocriptine | 1 | 2007 | 111 | 0.020 |
Why?
|
Occipital Lobe | 1 | 1989 | 380 | 0.020 |
Why?
|
Lipoproteins | 1 | 2012 | 876 | 0.020 |
Why?
|
Glycoproteins | 1 | 1995 | 2260 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 713 | 0.020 |
Why?
|
Ligation | 1 | 1987 | 453 | 0.020 |
Why?
|
Physicians, Family | 1 | 2008 | 345 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2008 | 20086 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1799 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13403 | 0.020 |
Why?
|
Carotid Artery, Internal | 1 | 1987 | 445 | 0.020 |
Why?
|
Drug Interactions | 1 | 2009 | 1458 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2003 | 25575 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2008 | 2335 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8425 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2017 | 3861 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1990 | 759 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1889 | 0.010 |
Why?
|
Chronic Disease | 1 | 1998 | 9144 | 0.010 |
Why?
|
Cell Division | 2 | 2002 | 4564 | 0.010 |
Why?
|
Family Characteristics | 1 | 2008 | 999 | 0.010 |
Why?
|
Infant | 2 | 2003 | 35070 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1990 | 1225 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16331 | 0.010 |
Why?
|
Protons | 1 | 2007 | 1126 | 0.010 |
Why?
|
Transfection | 2 | 2002 | 5892 | 0.010 |
Why?
|
Hormones | 1 | 2006 | 884 | 0.010 |
Why?
|
Olivary Nucleus | 1 | 1982 | 128 | 0.010 |
Why?
|
Cerebellar Cortex | 1 | 1982 | 107 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1995 | 5019 | 0.010 |
Why?
|
Lipids | 1 | 2012 | 3302 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 40450 | 0.010 |
Why?
|
Child, Preschool | 1 | 2003 | 40955 | 0.010 |
Why?
|
Mothers | 1 | 2011 | 2163 | 0.010 |
Why?
|
Activin Receptors | 1 | 2000 | 43 | 0.010 |
Why?
|
Prolactin-Releasing Hormone | 1 | 1999 | 3 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2015 | 0.010 |
Why?
|
Thymidine | 1 | 2000 | 309 | 0.010 |
Why?
|
Arousal | 1 | 2006 | 1165 | 0.010 |
Why?
|
Hypogonadism | 1 | 2006 | 798 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 335 | 0.010 |
Why?
|
Reference Values | 2 | 1998 | 4982 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 363 | 0.010 |
Why?
|
17-Hydroxycorticosteroids | 1 | 1998 | 40 | 0.010 |
Why?
|
Activin Receptors, Type I | 1 | 1999 | 142 | 0.010 |
Why?
|
Activins | 1 | 2000 | 208 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 72145 | 0.010 |
Why?
|
Mutation | 2 | 2020 | 29717 | 0.010 |
Why?
|
Activin Receptors, Type II | 1 | 1999 | 127 | 0.010 |
Why?
|
Affect | 1 | 2006 | 1473 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3766 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1998 | 248 | 0.010 |
Why?
|
Cyclins | 1 | 2000 | 601 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6891 | 0.010 |
Why?
|
Emotions | 1 | 2009 | 2657 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1998 | 6171 | 0.010 |
Why?
|
Radiography | 1 | 1987 | 7010 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2006 | 2050 | 0.010 |
Why?
|
United States | 1 | 2003 | 69693 | 0.010 |
Why?
|
MicroRNAs | 1 | 2011 | 3731 | 0.010 |
Why?
|
Endocrine System Diseases | 1 | 1997 | 248 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16665 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1998 | 794 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12242 | 0.010 |
Why?
|
Follistatin | 1 | 1995 | 141 | 0.010 |
Why?
|
Paranasal Sinuses | 1 | 1996 | 249 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 1995 | 216 | 0.010 |
Why?
|
Bone Density | 1 | 2006 | 3469 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4322 | 0.010 |
Why?
|
Blotting, Western | 1 | 2000 | 5180 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1782 | 0.010 |
Why?
|
Arteries | 1 | 1996 | 1118 | 0.010 |
Why?
|
Estradiol | 1 | 1998 | 2021 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1996 | 1285 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1999 | 4187 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 1990 | 112 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10372 | 0.010 |
Why?
|
Mental Disorders | 1 | 2009 | 6587 | 0.010 |
Why?
|
Research | 1 | 1997 | 1999 | 0.010 |
Why?
|
Cognition | 1 | 2006 | 6722 | 0.010 |
Why?
|
Meningomyelocele | 1 | 1989 | 165 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1990 | 610 | 0.000 |
Why?
|
Base Sequence | 1 | 1999 | 12797 | 0.000 |
Why?
|
Cerebellar Diseases | 1 | 1989 | 222 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1990 | 2645 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13814 | 0.000 |
Why?
|
Cerebral Ventricles | 1 | 1989 | 544 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15108 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1997 | 1617 | 0.000 |
Why?
|
Cytoplasm | 1 | 1990 | 1539 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 18112 | 0.000 |
Why?
|
Education, Medical, Graduate | 1 | 1997 | 2283 | 0.000 |
Why?
|
Microtubules | 1 | 1990 | 1090 | 0.000 |
Why?
|
Massachusetts | 1 | 1997 | 8662 | 0.000 |
Why?
|
Genetic Variation | 1 | 1998 | 6540 | 0.000 |
Why?
|
Anura | 1 | 1982 | 85 | 0.000 |
Why?
|
Glucose | 1 | 1995 | 4391 | 0.000 |
Why?
|
Cats | 1 | 1982 | 998 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7721 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1991 | 10943 | 0.000 |
Why?
|
Neural Pathways | 1 | 1982 | 2971 | 0.000 |
Why?
|
Brain Mapping | 1 | 1982 | 6669 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1982 | 21821 | 0.000 |
Why?
|
Mice | 1 | 1982 | 81045 | 0.000 |
Why?
|
Animals | 1 | 1982 | 168561 | 0.000 |
Why?
|